Literature DB >> 28522039

Injectable and topical neurotoxins in dermatology: Indications, adverse events, and controversies.

Cerrene N Giordano1, Seth L Matarasso2, David M Ozog3.   

Abstract

The use of neuromodulators for therapeutic and cosmetic indications has proven to be remarkably safe. While aesthetic and functional adverse events are uncommon, each anatomic region has its own set of risks of which the physician and patient must be aware before treatment. The therapeutic usages of botulinum toxins now include multiple specialties and multiple indications. New aesthetic indications have also developed, and there has been an increased utilization of combination therapies to combat the effects of global aging. In the second article in this continuing medical education series, we review the prevention and treatment of adverse events, therapeutic and novel aesthetic indications, controversies, and a brief overview of combination therapies.
Copyright © 2016 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  abobotulinum; adverse events; botulinum toxin; controversies; cosmetic uses; incobotulinum; neuromodulator; neurotoxin; onabotulinum; therapeutic uses

Mesh:

Substances:

Year:  2017        PMID: 28522039     DOI: 10.1016/j.jaad.2016.11.012

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  Causes of Botulinum Toxin Treatment Failure.

Authors:  Valentina Shtefan; James Fletcher; Olga Anna Duclos
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-06-07

Review 2.  Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures.

Authors:  Katharine E Alter; Barbara I Karp
Journal:  Toxins (Basel)       Date:  2017-12-28       Impact factor: 4.546

3.  AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients.

Authors:  Malgorzata Field; Andrew Splevins; Philippe Picaut; Marcel van der Schans; Jan Langenberg; Daan Noort; Keith Foster
Journal:  Toxins (Basel)       Date:  2018-12-13       Impact factor: 4.546

Review 4.  Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes.

Authors:  Greg J Goodman; Steven Liew; Peter Callan; Sarah Hart
Journal:  Australas J Dermatol       Date:  2020-03-22       Impact factor: 2.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.